Dr. Christopher P. Gayde Named Managing Director of Life Sciences Group at Hunter Wise Financial Group

IRVINE, Calif., Nov. 3 /PRNewswire/ -- Hunter Wise Financial Group, LLC is pleased to announce the appointment of Dr. Christopher P. Gayde as Managing Director of its Life Sciences Group. Dr. Gayde has relocated to the Irvine Corporate Headquarters from the Hunter Wise Michigan office and has been assigned to build the Hunter Wise corporate finance and mergers and acquisitions programs specifically focusing on Life Science Companies.

"We are very fortunate to have Dr. Gayde join us in Irvine," said Fred G. Jager, President, Hunter Wise Financial Group, LLC. "Chris has a unique background in clinical private practice, teaching, buying and selling of dental practices, and investment banking mergers and acquisitions. With the explosive growth in the Southern California Healthcare and Life Sciences industries in the past decade, we recognized the need for a specialist to handle these types of transactions. Dr. Gayde's skills are a perfect fit for the Hunter Wise client's corporate growth strategies."

Mr. Jager also emphasized that Hunter Wise, which provides mid-market investment banking services from 12 offices in the U.S., and offices in Beijing, London, and Vancouver, Canada, continues to grow and expand corporate services. Also under the Hunter Wise umbrella are Hunter Wise Commodities and Hunter Wise Capital Group.

Dr. Gayde earned a Bachelor's Degree in Biology and a Doctor of Dental Surgery from the University of Detroit. He also taught clinical dentistry at the University of Detroit and has a current DEA (Pharmaceutical) license. Chris has lectured extensively, authored several publications and also has his Series 7 and 66 Licenses.

    Contact:

    Dr. Christopher P. Gayde
    Hunter Wise Financial Group, LLC
    949/732-4114
    cgayde@hunterwise.com